Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Nefazodone (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Dorothy Hatsukami, Ph.D., Principal Investigator, Affiliation: University of Minnesota - Clinical and Translational Science Institute
Summary
The purpose of this study is to determine the effects of nefazedone on cocaine
self-administration in depressed and non-depressed female cocaine users.
Clinical Details
Official title: Effects of Nefazodone on Treatment of Female Cocaine Abusers
Study design: Masking: Double-Blind, Primary Purpose: Treatment
Primary outcome: CravingDrug use Depression Life functioning HIV risk behaviors
Detailed description:
This study evaluated the effect of nefazodone on reducing cocaine use and craving in both
depressed and nondepressed women and if there was a greater effect in depressed women.
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
Females, ages 18-55, minimum use of 8 days of the last 30, minimum of 8th grade education,
current diagnosis of cocaine abuse/dependence
Exclusion Criteria:
Unstable medical illness, dx of MR, OBS, bipolar
Locations and Contacts
University of Minnesota, Minneapolis, Minnesota 55455, United States
Additional Information
Starting date: December 1996
Last updated: June 2, 2015
|
